APA (7th ed.) Citation

Palmeri, S., Vaglica, M., Spada, S., Filippelli, G., Farris, A., Massidda, B., . . . Danova, M. (2005). Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study. Oncology, 68(4-6), 438. https://doi.org/10.1159/000086986

Chicago Style (17th ed.) Citation

Palmeri, S., et al. "Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study." Oncology 68, no. 4-6 (2005): 438. https://doi.org/10.1159/000086986.

MLA (9th ed.) Citation

Palmeri, S., et al. "Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study." Oncology, vol. 68, no. 4-6, 2005, p. 438, https://doi.org/10.1159/000086986.